Survivin degradation by bergenin overcomes pemetrexed resistance.
Cell Oncol (Dordr)
; 46(6): 1837-1853, 2023 Dec.
Article
in En
| MEDLINE
| ID: mdl-37542022
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Cell Oncol (Dordr)
Year:
2023
Document type:
Article
Country of publication:
Países Bajos